Andrew Wang
Overview
Explore the profile of Andrew Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
375
Citations
8682
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dhull A, Park K, Dar A, Wang A, Rani A, Sharma R, et al.
ACS Sens
. 2025 Feb;
PMID: 40020085
Surgical site infections (SSIs) remain the most common cause for readmission following surgery and are associated with significant medical comorbidities. Distinguishing between inflammation and early infection postsurgery is a critical...
2.
Maksabedian Hernandez E, Krishnaswami S, Dubey A, Singh N, Jonkman A, Cao Z, et al.
J Med Econ
. 2025 Feb;
28(1):302-313.
PMID: 39973329
Aim: We assessed the relationship between hospital septal reduction therapy (SRT) procedural volume and clinical outcomes, healthcare resource utilization, and hospital costs. Methods: This cross-sectional study used 2012-2022 US hospital...
3.
Kwak S, Kim J, Park C, Lee H, Park J, Lee S, et al.
Korean Circ J
. 2025 Feb;
PMID: 39962967
Background And Objectives: The prognostic implication of coexisting hypertension in patients with hypertrophic cardiomyopathy (HCM) is poorly defined. This study aimed to evaluate the association between left ventricular global longitudinal...
4.
Gaca J, Zwischenberger B, Carr K, Wang A, Glower D
Innovations (Phila)
. 2025 Feb;
20(1):80-86.
PMID: 39953732
Objective: Axillary artery cannulation techniques continue to improve and find application throughout cardiac surgery. Yet, early outcomes are poorly documented versus femoral or central arterial cannulation in right minithoracotomy mitral...
5.
Endoscopy volume and outcomes after the COVID-19 pandemic: results from a tertiary Australian centre
Peverelle M, Hirsch R, Slifirski W, Ea V, Sun G, Sane N, et al.
Intern Med J
. 2025 Feb;
55(2):337-338.
PMID: 39937434
No abstract available.
6.
Garcia-Pavia P, Bilen O, Burroughs M, Costabel J, de Barros Correia E, Dybro A, et al.
JACC Heart Fail
. 2025 Feb;
13(2):346-357.
PMID: 39909646
Beta-blockers and nondihydropyridine calcium-channel blockers have been standard-of-care (SOC) medications for patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), even though these agents do not directly affect the underlying pathophysiology of...
7.
Jaschke N, Wang A
Immunity
. 2025 Feb;
58(2):279-294.
PMID: 39909034
As a highly diverse and mobile organ, the immune system is uniquely equipped to participate in tissue responses in a tunable manner, depending on the number, type, and nature of...
8.
Parizher G, Haouzi A, Jaber W, Owens A, Wolski K, Geske J, et al.
J Am Soc Echocardiogr
. 2024 Dec;
PMID: 39733991
No abstract available.
9.
Wang A, Lakdawala N, Abraham T, Nilles E, Wojdyla D, Owens A, et al.
J Card Fail
. 2024 Dec;
PMID: 39653325
Background And Aims: In patients with symptomatic, obstructive hypertrophic cardiomyopathy (HCM), it is unclear if response to cardiac myosin inhibition varies with older age or a longer duration of diagnosis....
10.
Minnery M, Okoyo C, Morgan G, Wang A, Johnson O, Fronterre C, et al.
PLoS Negl Trop Dis
. 2024 Dec;
18(12):e0011583.
PMID: 39621813
Background: Soil-transmitted helminths (STH) and schistosomiasis comprise the most wide-spread NTDs globally. Preventative chemotherapy is a cost-effective approach to controlling morbidity of both diseases, but relies on large scale surveys...